Enanta Pharmaceuticals (ENTA)
(Delayed Data from NSDQ)
$15.17 USD
+1.26 (9.06%)
Updated May 3, 2024 04:00 PM ET
After-Market: $15.18 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Enanta Pharmaceuticals, Inc. [ENTA]
Reports for Purchase
Showing records 141 - 160 ( 163 total )
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotech''s Untapped Market Opportunities in 2019- Part 3 - RSV
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
2019 Is a Big Year for RSV: Join in Our Expert Call to Find Out Why
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
Setting in Motion a Vital 2019 with Multiple In-House Programs
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
Healthcare: Biotech''s 2019 Untapped Market Opportunities: 2019 Is the Best NASH Year
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
Healthcare -Yas'' Weekly Recap - What the Buy-side Reads
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
Healthcare - AASLD Nonsense - Sense and the War of FXR Agonists
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
Healthcare - The Liver Meeting Abstracts Part 1: Our Coverage Universe
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
Healthcare - Love NASH, Mark Your Calendar for October 17
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
Healthcare -Join Us for Battle of the NASH Thrones Investor Conference in NYC on Oct. 17
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
3Q18 - Express Scripts News Just a Drop in the Bucket
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
We are initiating coverage of Enanta Pharmaceuticals, Inc. with a Buy rating
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y